These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 9262154

  • 1. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
    Piercey MF, Hyslop DK, Hoffmann WE.
    Brain Res; 1997 Jul 11; 762(1-2):19-28. PubMed ID: 9262154
    [Abstract] [Full Text] [Related]

  • 2. Excitation of type II caudate neurons by systemic administration of dopamine agonists.
    Piercey MF, Hyslop DK, Hoffmann WE.
    Brain Res; 1996 Jan 15; 706(2):249-58. PubMed ID: 8822364
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G, Zanetti S, Missale C, Spano P.
    Eur J Neurosci; 2008 Oct 15; 28(7):1231-40. PubMed ID: 18973551
    [Abstract] [Full Text] [Related]

  • 4. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS, Bergstrom DA, Gonzalez AM, Huang KX, Sibley DR, Walters JR.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):209-14. PubMed ID: 7493610
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
    Piercey MF, Hoffmann WE, Smith MW, Hyslop DK.
    Eur J Pharmacol; 1996 Sep 19; 312(1):35-44. PubMed ID: 8891576
    [Abstract] [Full Text] [Related]

  • 6. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
    Koffarnus MN, Greedy B, Husbands SM, Grundt P, Newman AH, Woods JH.
    Psychopharmacology (Berl); 2009 Apr 19; 203(2):317-27. PubMed ID: 18807248
    [Abstract] [Full Text] [Related]

  • 7. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 19; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 8. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
    Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N.
    Eur J Pharmacol; 1994 Oct 03; 263(3):235-43. PubMed ID: 7843260
    [Abstract] [Full Text] [Related]

  • 9. PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects.
    Akunne HC, Zoski KT, Davis MD, Cooke LW, Meltzer LT, Whetzel SZ, Shih YH, Wustrow DJ, Wise LD, MacKenzie RG, Georgic LM, Heffner TG, Pugsley TA.
    Neuropharmacology; 2000 Apr 27; 39(7):1197-210. PubMed ID: 10760362
    [Abstract] [Full Text] [Related]

  • 10. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
    Siuciak JA, Fujiwara RA.
    Psychopharmacology (Berl); 2004 Sep 27; 175(2):163-9. PubMed ID: 14985923
    [Abstract] [Full Text] [Related]

  • 11. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats.
    Lagos P, Scorza C, Monti JM, Jantos H, Reyes-Parada M, Silveira R, Ponzoni A.
    Eur Neuropsychopharmacol; 1998 May 27; 8(2):113-20. PubMed ID: 9619689
    [Abstract] [Full Text] [Related]

  • 12. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
    Caine SB, Geyer MA, Swerdlow NR.
    Neuropsychopharmacology; 1995 Apr 27; 12(2):139-45. PubMed ID: 7779242
    [Abstract] [Full Text] [Related]

  • 13. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS.
    Pharmacol Res; 2001 Mar 27; 43(3):283-90. PubMed ID: 11401421
    [Abstract] [Full Text] [Related]

  • 14. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB, Dombrowski PA, Da Cunha C, Fischer L, Ferraz AC, Lima MM.
    Neuropharmacology; 2014 Jan 27; 76 Pt A():118-26. PubMed ID: 24012539
    [Abstract] [Full Text] [Related]

  • 15. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors.
    Wicke K, Garcia-Ladona J.
    Eur J Pharmacol; 2001 Jul 20; 424(2):85-90. PubMed ID: 11476753
    [Abstract] [Full Text] [Related]

  • 16. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B, Rothwell LA, Seabrook GR.
    Br J Pharmacol; 1994 Jul 20; 112(3):873-80. PubMed ID: 7921615
    [Abstract] [Full Text] [Related]

  • 17. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
    Bowery BJ, Razzaque Z, Emms F, Patel S, Freedman S, Bristow L, Kulagowski J, Seabrook GR.
    Br J Pharmacol; 1996 Dec 20; 119(7):1491-7. PubMed ID: 8968560
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M, von Euler G.
    Neurochem Int; 2001 Jan 20; 38(1):31-42. PubMed ID: 10913686
    [Abstract] [Full Text] [Related]

  • 19. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
    Eltayb A, Lindblom S, Oerther S, Ahlenius S.
    Acta Physiol Scand; 2001 Jul 20; 172(3):205-9. PubMed ID: 11472307
    [Abstract] [Full Text] [Related]

  • 20. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
    Waters N, Lagerkvist S, Löfberg L, Piercey M, Carlsson A.
    Eur J Pharmacol; 1993 Sep 28; 242(2):151-63. PubMed ID: 8253112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.